Article Text
Abstract
The paper by Mand et al raises important questions about the predictive genetic testing of children. They focus on those claims made by professionals that are open to empirical enquiry and give too little weight to those claims that do not require empirical support. The authors remind us that some commentators oppose empirical enquiry because of the concern that gathering evidence of the consequences of such testing may itself be harmful or unethical. They respond by asserting that the relevant research questions are ‘eminently testable’ but fail to discuss the challenges of such research, including the questions of timescale, consent or the nature of the data whose collection (they assert) would resolve the perceived difficulties with the genetic testing of children. They conclude that empirical research is required without resolving the weighty arguments against predictive testing of young children or explaining how the evidence they wish to collect could overcome the force of the arguments that favour caution.
- Clinical genetics
- social science research on genetics
- newborn screening
- genetic counselling
Statistics from Altmetric.com
Footnotes
Linked article 100055.R1.
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.
Linked Articles
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments
- Predictive genetic testing in children and adults: a study of emotional impact
- Primary prevention of neurological illness early in life
- Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes
- What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
- The complexities of predictive genetic testing
- Paradox of a better test for Huntington's disease
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation
- Huntington’s disease
- Highlights from this issue